Principal Financial Group reports Q2 results on July 28 with options positioning sending its clearest bullish signal in months — a sharp contrast to where sentiment stood just weeks ago.
The most striking shift is in options flow. Call demand has surged so aggressively that the put/call ratio has collapsed to 0.24 — more than 1.3 standard deviations below its 20-day average of 0.90. As recently as early July, that ratio was running above 1.35, reflecting heavy hedging demand. The reversal is sharp and fast: the PCR touched its 52-week low of 0.14 mid-last week before settling slightly higher into the print. That kind of swing suggests traders who were bracing for downside have largely stepped aside, replaced by buyers of upside exposure.
The short side tells a complementary story of easing pressure. Short interest at 3.9% of free float is not elevated by any historical standard, and a 10% decline from late June levels shows bears have been covering steadily. Borrow conditions confirm there is no friction here — availability is extremely loose at over 1,100%, meaning shares to borrow vastly outnumber shares already shorted. Borrowing costs are modest at 0.44% annually, barely above a year ago. Nothing in the lending market signals a squeeze setup or forced positioning ahead of the report.
Analyst opinion heading into the print is cautiously constructive but not enthusiastic. Multiple firms raised targets in the weeks before earnings — Wells Fargo, JP Morgan, Evercore ISI, Keefe Bruyette, Jefferies, and Morgan Stanley all lifted numbers in July — yet none upgraded their rating. Every one of those firms stays at neutral-equivalent stances, with targets now clustered around $106–$114 against a current price of $111.29. The lone outlier is Barclays, sitting at Underweight with a $92 target. Bank of America downgraded to Underperform in late June, cutting to $95, which keeps a meaningful bear case on the table. The Street consensus essentially says the stock is fairly valued here; the recent target hikes reflect a better fundamental backdrop after a stronger-than-expected Q1, not a conviction call on further upside. Piper Sandler is the only bull with an Overweight and a $125 target that implies real room to run.
The insider picture adds a mild cautionary note. CEO Deanna Strable-Soethout sold roughly $5.6 million worth of shares in mid-June across two days, a meaningful clip even for a large-cap executive. A divisional president also sold throughout April and May. The net insider activity over the past 90 days reflects net selling of around $8.5 million. These sales occurred on a planned basis and the amounts are modest relative to the company's overall share count — but the direction is worth noting when the stock is trading near multi-month highs.
The earnings history offers a useful frame. The last three reported quarters each produced positive price reactions on the day, ranging from roughly 0.4% to 2.8%, with five-day drifts also positive in every case. The print will test whether a cleaner options setup and a reset in analyst expectations can sustain that pattern — or whether the gap between the lone bull's $125 target and the bear camp's sub-$95 view finally forces a resolution.
See the live data behind this article on ORTEX.
Open PFG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
